Rajaraman G, Roberts M S, Hung D, Wang G Q, Burczynski F J
Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Pharm Res. 2005 Nov;22(11):1793-804. doi: 10.1007/s11095-005-7248-2. Epub 2005 Aug 16.
The hepatic transmembrane flux of long-chain fatty acids (LCFA) occurs through passive and fatty acid transport protein facilitated processes from blood. The extent that these transport processes can be related to the unbound and protein-bound fractions of LCFA in blood is not clear.
We used hepatocyte suspensions, hepatoma monolayers, and perfused rat livers to quantitate the transport of purified [(3)H]palmitate ([(3)H]PA) and 12-(N-methyl)-N-[(7-nitrobenz-2oxa-1,3-diazol-4yl-)amino]octadecanoicacid (12-NBDS) from solutions with a constant unbound LCFA concentration with varying bovine serum albumin (BSA) concentrations and in the presence and absence of antisera raised against cytosolic liver fatty acid binding protein (L-FABP).
In the absence of L-FABP antisera, using an unbound ligand concentration that was adjusted to remain constant at each BSA concentration, hepatocyte [(3)H]PA and 12-NBDS uptake rates increased linearly with an increase in BSA concentration (p < 0.0001). In the presence of L-FABP antisera, [(3)H]PA uptake showed a greater reduction in the presence of 100 muM BSA than 5 muM BSA. The calculated permeability surface area product (PS) confirmed that both unbound and bound fractions of LCFA contributed to the overall flux, but only the PS for the protein-bound fraction was reduced in the presence of L-FABP antisera. In situ rat liver perfusion studies showed that the only rate process for the disposition of [(3)H]PA in the liver inhibited by L-FABP antisera was that for influx, as defined by PS, and that it reduced PS in the perfused liver by 42%.
These results suggest that, at physiological albumin concentrations, most of the LCFA uptake is mediated from that bound to albumin by a hepatocyte basolateral membrane transport protein, and uptake of unbound LCFA occurring by passive diffusion contributes a minor component.
长链脂肪酸(LCFA)的肝跨膜通量通过被动和脂肪酸转运蛋白促进的过程从血液中发生。这些转运过程与血液中LCFA的未结合和蛋白结合部分的关联程度尚不清楚。
我们使用肝细胞悬液、肝癌单层细胞和灌注大鼠肝脏,从具有恒定未结合LCFA浓度、不同牛血清白蛋白(BSA)浓度的溶液中,在存在和不存在针对细胞溶质肝脂肪酸结合蛋白(L-FABP)产生的抗血清的情况下,定量纯化的[(3)H]棕榈酸酯([(3)H]PA)和12-(N-甲基)-N- [(7-硝基苯并-2-恶唑-1,3-二氮杂环丁烷-4-基)氨基]十八烷酸(12-NBDS)的转运。
在不存在L-FABP抗血清的情况下,使用在每个BSA浓度下调整为保持恒定的未结合配体浓度,肝细胞[(3)H]PA和12-NBDS摄取率随BSA浓度的增加呈线性增加(p <0.0001)。在存在L-FABP抗血清的情况下,[(3)H]PA摄取在100μM BSA存在下比5μM BSA存在下表现出更大的降低。计算的通透表面积乘积(PS)证实,LCFA的未结合和结合部分均对总通量有贡献,但仅蛋白结合部分的PS在存在L-FABP抗血清的情况下降低。原位大鼠肝脏灌注研究表明,L-FABP抗血清抑制肝脏中[(3)H]PA处置的唯一速率过程是由PS定义的流入过程,并且它使灌注肝脏中的PS降低了42%。
这些结果表明,在生理白蛋白浓度下,大多数LCFA摄取是由肝细胞基底外侧膜转运蛋白从与白蛋白结合的部分介导的,而通过被动扩散发生的未结合LCFA摄取贡献较小。